Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDUFB2 antisense RNA 1 (NDUFB2-AS1)
- Target
- NDUFB2-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Other (Non-coding RNA)
01
Overview
NDUFB2 antisense RNA 1 (NDUFB2-AS1) is a long non-coding RNA (lncRNA) located on chromosome 11, transcribed from the strand opposite the protein-coding NDUFB2 gene, which encodes a subunit of mitochondrial complex I. NDUFB2-AS1 is approximately 3,000 nucleotides in length, does not encode a protein, and its precise biological function is not fully elucidated. It is postulated to regulate the expression of the NDUFB2 gene—implicating a potential regulatory role in mitochondrial respiration and cellular energy production—but definitive functional data remain limited. Notably, NDUFB2-AS1 has been reported as a prognostic biomarker in several cancer types, suggesting disease relevance, although it is not directly established as a therapeutic target. There is no information available on drug interactions or specific mechanisms of action, nor established safety or therapeutic challenge data.
- Other names
- NDUFB2 antisense RNA 1 (non-protein coding)NDUFB2-AS1
02
Biological functions
Regulation of gene expressionPotential regulation of mitochondrial function (inferred from antisense to NDUFB2)
03
Disease associations
Cancer (notably as a prognostic biomarker in various cancer types)Other (proposed involvement, not definitively established)
04
Biomarkers
Prognostic biomarker in various cancer types
Beyond the preview
Go deeper on NDUFB2 antisense RNA 1 (NDUFB2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NDUFB2 antisense RNA 1 (NDUFB2-AS1).